2024 Q3 Form 10-Q Financial Statement

#000147793224005698 Filed on September 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $666.4K $630.0K
YoY Change 5.76% 18.86%
Cost Of Revenue $19.89K $12.68K
YoY Change 56.86%
Gross Profit $646.5K $617.4K
YoY Change 4.72%
Gross Profit Margin 97.02% 97.99%
Selling, General & Admin $535.8K $550.9K
YoY Change -2.74% 9.42%
% of Gross Profit 82.88% 89.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $603.00 $618.00
YoY Change -2.43% -3.59%
% of Gross Profit 0.09% 0.1%
Operating Expenses $556.3K $564.2K
YoY Change -1.4% 11.92%
Operating Profit $110.1K $65.88K
YoY Change 67.09% 153.25%
Interest Expense $5.170K -$15.17K
YoY Change -134.08% 58.68%
% of Operating Profit 4.7% -23.03%
Other Income/Expense, Net $11.63K -$265.00
YoY Change -4489.81% -113.87%
Pretax Income $121.7K $65.62K
YoY Change 85.49% 257.28%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $121.7K $65.62K
YoY Change 85.49% 257.28%
Net Earnings / Revenue 18.27% 10.41%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 53.14M shares 53.14M shares
Diluted Shares Outstanding 61.22M shares 60.01M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.127M $858.4K
YoY Change 31.32% 27.68%
Cash & Equivalents $1.127M $858.4K
Short-Term Investments
Other Short-Term Assets $12.58K $10.88K
YoY Change 15.63% -21.78%
Inventory
Prepaid Expenses $12.58K $10.88K
Receivables $228.0K $324.1K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.368M $1.198M
YoY Change 14.15% 28.03%
LONG-TERM ASSETS
Property, Plant & Equipment $2.763K $5.380K
YoY Change -48.64% -33.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $2.765K $5.380K
YoY Change -48.61% -33.97%
TOTAL ASSETS
Total Short-Term Assets $1.368M $1.198M
Total Long-Term Assets $2.765K $5.380K
Total Assets $1.371M $1.204M
YoY Change 13.87% 27.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $144.4K $109.8K
YoY Change 31.56% 833.5%
Accrued Expenses $164.8K $153.3K
YoY Change 7.45% 13.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $616.5K $619.9K
YoY Change -0.56% 49.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $616.5K $619.9K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $616.5K $619.9K
YoY Change -0.56% 40.04%
SHAREHOLDERS EQUITY
Retained Earnings -$6.591M -$6.623M
YoY Change -0.49% 1.08%
Common Stock $53.15K $53.15K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $754.1K $583.7K
YoY Change
Total Liabilities & Shareholders Equity $1.371M $1.204M
YoY Change 13.87% 27.5%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income $121.7K $65.62K
YoY Change 85.49% 257.28%
Depreciation, Depletion And Amortization $603.00 $618.00
YoY Change -2.43% -3.59%
Cash From Operating Activities $92.01K $95.46K
YoY Change -3.61% -20.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -14.76K
YoY Change -100.0% 129.55%
NET CHANGE
Cash From Operating Activities 92.01K 95.46K
Cash From Investing Activities
Cash From Financing Activities 0.000 -14.76K
Net Change In Cash 92.01K 80.70K
YoY Change 14.01% -29.22%
FREE CASH FLOW
Cash From Operating Activities $92.01K $95.46K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2763 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4554 usd
CY2024Q3 us-gaap Assets
Assets
1370597 usd
CY2023Q4 us-gaap Assets
Assets
1256545 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
144433 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
84870 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
307262 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
360170 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
616450 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
540905 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
306255 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12584 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1367832 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1251991 usd
CY2024Q3 us-gaap Liabilities
Liabilities
616450 usd
CY2023Q4 us-gaap Liabilities
Liabilities
540905 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
5 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
5 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
916780 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
228042 usd
CY2024Q3 skky Accounts Receivable Related Party Current
AccountsReceivableRelatedPartyCurrent
0 usd
CY2023Q4 skky Accounts Receivable Related Party Current
AccountsReceivableRelatedPartyCurrent
4695 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24261 usd
CY2024Q3 skky Related Party Transaction Amounts Of Transaction Accrued Liabilities
RelatedPartyTransactionAmountsOfTransactionAccruedLiabilities
164755 usd
CY2023Q4 skky Related Party Transaction Amounts Of Transaction Accrued Liabilities
RelatedPartyTransactionAmountsOfTransactionAccruedLiabilities
95865 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7206658 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7146991 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
85038 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74082 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6590893 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6558777 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
754147 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
715640 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1370597 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1256545 usd
us-gaap Revenues
Revenues
1747623 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-147206 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
578252 usd
us-gaap Profit Loss
ProfitLoss
-23401 usd
us-gaap Profit Loss
ProfitLoss
-165403 usd
us-gaap Depreciation
Depreciation
1821 usd
us-gaap Depreciation
Depreciation
1839 usd
us-gaap Share Based Compensation
ShareBasedCompensation
59667 usd
us-gaap Share Based Compensation
ShareBasedCompensation
78788 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
78213 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53406 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
59563 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
51576 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
64870 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
29013 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11677 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14857 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52908 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
75194 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
199502 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
139270 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-19106 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19106 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10924 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8270 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
210426 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
128434 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
916780 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
729936 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1127206 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
858370 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
skky Dividends Accrued On Series B Preferred Share
DividendsAccruedOnSeriesBPreferredShare
8715 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001546853
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53143822 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53143822 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53143822 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54747
dei Entity Registrant Name
EntityRegistrantName
SKKYNET CLOUD SYSTEMS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3757848
dei Entity Address Address Line1
EntityAddressAddressLine1
2233 Argentia Road Suite 302
dei Entity Address City Or Town
EntityAddressCityOrTown
Mississauga
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L5N 2X7
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
702-7851
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53143822 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1127206 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
89333 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
86930 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53143822 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
53145 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
53145 usd
CY2024Q3 us-gaap Revenues
Revenues
666359 usd
CY2023Q3 us-gaap Revenues
Revenues
630040 usd
us-gaap Revenues
Revenues
1898701 usd
us-gaap Revenues
Revenues
1747623 usd
CY2024Q3 us-gaap Depreciation
Depreciation
603 usd
CY2023Q3 us-gaap Depreciation
Depreciation
618 usd
us-gaap Depreciation
Depreciation
1821 usd
us-gaap Depreciation
Depreciation
1839 usd
CY2024Q3 us-gaap Salaries And Wages
SalariesAndWages
424279 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
316883 usd
us-gaap Salaries And Wages
SalariesAndWages
1190888 usd
us-gaap Salaries And Wages
SalariesAndWages
1066013 usd
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
1790 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
127061 usd
us-gaap Advertising Expense
AdvertisingExpense
235800 usd
us-gaap Advertising Expense
AdvertisingExpense
347658 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
19889 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12679 usd
us-gaap Share Based Compensation
ShareBasedCompensation
59667 usd
us-gaap Share Based Compensation
ShareBasedCompensation
78788 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
109713 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106916 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
464157 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
438929 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
556274 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
564157 usd
us-gaap Operating Expenses
OperatingExpenses
1952333 usd
us-gaap Operating Expenses
OperatingExpenses
1933227 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
110085 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
65883 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-53632 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-185604 usd
CY2024Q3 us-gaap Other Income
OtherIncome
6464 usd
CY2023Q3 us-gaap Other Income
OtherIncome
14900 usd
us-gaap Other Income
OtherIncome
14459 usd
us-gaap Other Income
OtherIncome
14960 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5169 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-15165 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-12502 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24727 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11633 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-265 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1957 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9767 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
121718 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65618 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51675 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-195371 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28274 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29968 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
121718 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
65618 usd
us-gaap Net Income Loss
NetIncomeLoss
-23401 usd
us-gaap Net Income Loss
NetIncomeLoss
-165403 usd
CY2024Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2905 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2905 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
8715 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
8715 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
118813 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
62713 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32116 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-174118 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-179 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6967 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-10956 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8431 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
118634 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
55746 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21160 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-165687 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53143822 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53143822 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53143822 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53143822 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61217272 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60013772 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53143822 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53143822 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
670596 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52283 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5484 usd
CY2023Q1 skky Dividend Accrued On Series B Preferred Shares
DividendAccruedOnSeriesBPreferredShares
-2905 usd
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13826 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4020 usd
CY2023Q2 skky Dividend Accrued On Series B Preferred Shares
DividendAccruedOnSeriesBPreferredShares
-2905 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-83815 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
501338 usd
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
12679 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6967 usd
CY2023Q3 skky Dividend Accrued On Series B Preferred Shares
DividendAccruedOnSeriesBPreferredShares
-2905 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
65618 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
583697 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
715640 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5472 usd
CY2024Q1 skky Dividend Accrued On Series B Preferred Shares
DividendAccruedOnSeriesBPreferredShares
-2905 usd
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
19889 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
21384 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
759480 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5305 usd
CY2024Q2 skky Dividend Accrued On Series B Preferred Shares
DividendAccruedOnSeriesBPreferredShares
-2905 usd
CY2024Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
19889 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-166503 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
615266 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
179 usd
CY2024Q3 skky Dividend Accrued On Series B Preferred Shares
DividendAccruedOnSeriesBPreferredShares
-2905 usd
CY2024Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
19889 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
121718 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
754147 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
skky Dividends Accrued On Series B Preferred Share
DividendsAccruedOnSeriesBPreferredShare
8715 usd
us-gaap Deferred Sales Inducements Adjustments
DeferredSalesInducementsAdjustments
247356 usd
skky Deferred Sales Revanue Recognized
DeferredSalesRevanueRecognized
194201 usd
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
307262 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
360170 usd
skky Revenue Recognition Percentage Of Completion
RevenueRecognitionPercentageOfCompletion
1 pure
us-gaap Revenues
Revenues
1898701 usd
skky Revenue Recognition Percentage Of Completion
RevenueRecognitionPercentageOfCompletion
1 pure
skky Revenue Recognition Percentage Of Completion
RevenueRecognitionPercentageOfCompletion
1 pure
us-gaap Revenues
Revenues
1898701 usd
skky Revenue Recognition Percentage Of Completion
RevenueRecognitionPercentageOfCompletion
1 pure
us-gaap Revenues
Revenues
1747623 usd
CY2024Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.7234 pure
CY2024Q3 skky Related Party Transaction Amounts Of Transaction Accrued Liabilities
RelatedPartyTransactionAmountsOfTransactionAccruedLiabilities
164755 usd
CY2023Q4 skky Related Party Transaction Amounts Of Transaction Accrued Liabilities
RelatedPartyTransactionAmountsOfTransactionAccruedLiabilities
95865 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6632450 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.15
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5100960 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
256000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1754750 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.19
CY2023 skky Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
P9Y3M
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
313750 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8073450 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.16
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M6D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6157950 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1320431 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8073450 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.16
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6443200 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3064093 usd
CY2023Q2 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
14756 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd

Files In Submission

Name View Source Status
0001477932-24-005698-index-headers.html Edgar Link pending
0001477932-24-005698-index.html Edgar Link pending
0001477932-24-005698.txt Edgar Link pending
0001477932-24-005698-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skky-20240731.xsd Edgar Link pending
skky_10q.htm Edgar Link pending
skky_ex311.htm Edgar Link pending
skky_ex312.htm Edgar Link pending
skky_ex321.htm Edgar Link pending
skky_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
skky-20240731_cal.xml Edgar Link unprocessable
skky-20240731_def.xml Edgar Link unprocessable
skky-20240731_lab.xml Edgar Link unprocessable
skky-20240731_pre.xml Edgar Link unprocessable
skky_10q_htm.xml Edgar Link completed